another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict .
the total amount paid out in life claims was £129.4m, with £13.46m paid in terminal illness claims. .
the publication�s purpose is to be a "force for good and a platform for much needed change and to generate critical debate". .